Ramsey Sfeir, MD | |
1840 Amherst Street, Winchester, VA 22601 | |
(540) 536-8000 | |
Not Available |
Full Name | Ramsey Sfeir |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 40 Years |
Location | 1840 Amherst Street, Winchester, Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023083490 | NPI | - | NPPES |
005730198 | Medicaid | VA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 0101044788 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Winchester Medical Center | Winchester, VA | Hospital |
Warren Memorial Hospital | Front royal, VA | Hospital |
Shenandoah Memorial Hospital | Woodstock, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Winchester Anesthesiologists Inc | 5092608067 | 68 |
News Archive
Cross Country Healthcare, Inc., a leading provider of advisory and workforce solutions, including contingent staffing, permanent placement and other consultative services for healthcare clients, today announced the results from a nationally represented survey of nurses and nursing students showing that the COVID-19 pandemic has introduced long-lasting negative perceptions of their future careers.
A team of scientists reports that a small molecule compound showed significant success in controlling the infectivity and spread of three polyomaviruses in human cell cultures. To date there has been no medicine approved to treat such viruses, which prey on transplant recipients, people with HIV, and others whose immune systems have been weakened.
AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its E. coli/P. aeruginosa PNA FISH® and EK/P. aeruginosa PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes.
Bristol-Myers Squibb Company today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that Daklinza (daclatasvir), an investigational, potent pan-genotypic NS5A complex inhibitor (in vitro), be granted approval for use in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults.
› Verified 7 days ago
Entity Name | Winchester Anesthesiologists Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700841137 PECOS PAC ID: 5092608067 Enrollment ID: O20040204000208 |
News Archive
Cross Country Healthcare, Inc., a leading provider of advisory and workforce solutions, including contingent staffing, permanent placement and other consultative services for healthcare clients, today announced the results from a nationally represented survey of nurses and nursing students showing that the COVID-19 pandemic has introduced long-lasting negative perceptions of their future careers.
A team of scientists reports that a small molecule compound showed significant success in controlling the infectivity and spread of three polyomaviruses in human cell cultures. To date there has been no medicine approved to treat such viruses, which prey on transplant recipients, people with HIV, and others whose immune systems have been weakened.
AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its E. coli/P. aeruginosa PNA FISH® and EK/P. aeruginosa PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes.
Bristol-Myers Squibb Company today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that Daklinza (daclatasvir), an investigational, potent pan-genotypic NS5A complex inhibitor (in vitro), be granted approval for use in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Ramsey Sfeir, MD Po Box 3297, Winchester, VA 22604-2497 Ph: (540) 662-8336 | Ramsey Sfeir, MD 1840 Amherst Street, Winchester, VA 22601 Ph: (540) 536-8000 |
News Archive
Cross Country Healthcare, Inc., a leading provider of advisory and workforce solutions, including contingent staffing, permanent placement and other consultative services for healthcare clients, today announced the results from a nationally represented survey of nurses and nursing students showing that the COVID-19 pandemic has introduced long-lasting negative perceptions of their future careers.
A team of scientists reports that a small molecule compound showed significant success in controlling the infectivity and spread of three polyomaviruses in human cell cultures. To date there has been no medicine approved to treat such viruses, which prey on transplant recipients, people with HIV, and others whose immune systems have been weakened.
AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its E. coli/P. aeruginosa PNA FISH® and EK/P. aeruginosa PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes.
Bristol-Myers Squibb Company today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that Daklinza (daclatasvir), an investigational, potent pan-genotypic NS5A complex inhibitor (in vitro), be granted approval for use in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults.
› Verified 7 days ago
Richard B Batchelet, DO Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1840 Amherst St, Winchester, VA 22603 Phone: 540-536-8000 | |
Claudia Viens, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1840 Amherst St, Winchester, VA 22601 Phone: 540-536-8000 Fax: 540-536-7780 | |
John E Davis Iii, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1840 Amherst St, Winchester, VA 22601 Phone: 540-536-8000 | |
Alison C Hessberg, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 878 Fox Dr, Winchester, VA 22603 Phone: 540-662-8336 Fax: 540-662-8593 | |
Dr. Lynn M Nieman, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 878 Fox Dr, Winchester, VA 22603 Phone: 540-662-8336 Fax: 540-662-8593 | |
Alok Gopal, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 190 Campus Blvd, Ste 420, Winchester, VA 22601 Phone: 540-536-1616 Fax: 540-536-6464 |